Efficiency of plasmid delivery and expression after lipid-mediated gene transfer to human cells in vitro

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 3, 1996, Pages 1462-1469

  Bebök, Zsuzsa ^a   Abai, Anna M ^d   Dong, Jian Yun ^e   King, Scott A ^a,b   Kirk, Kevin L ^a,b   Berta, Gabor ^a   Hughes, Brian W ^b   Kraft, Andrew S ^c   Burgess, Stephen W ^f   Shaw, Walter ^f   Felgner, Philip L ^d   Sorscher, Eric J ^a,b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d VICAL INC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Avanti Polar Lipids Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMYRISTOYL 3 TRIMETHYLAMMONIUM PROPANE; 1,2 DIOLEOYLOXYPROPYL 3 TRIMETHYLAMMONIUM BROMIDE; 2,3 DIOLEOYLOXY N [2 SPERMINE CARBOXAMIDO)ETHYL] N,N DIMETHYL 1 PROPANAMINIUM TRIFLUOROACETATE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; LIPOSOME; PLASMID DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CYSTIC FIBROSIS; DNA SEQUENCE; DRUG FORMULATION; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BETA-GALACTOSIDASE; CELL LINE; DNA, RECOMBINANT; GENE TRANSFER TECHNIQUES; HELA CELLS; HLA-B7 ANTIGEN; HUMANS; LIPOSOMES; PLASMIDS;

EID: 12644287544     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. ALTON, E. W. F. W., MIDDLETON, P. G., CAPLEN, N. J., SMITH, S. N., STEEL, D. M., MUNKONGE, F. M., JEFFERY, P. K., GED, D. M., HART, S. L., WILLIAMSON, R., FASOLD, K. I., MILLER, A. D., DICKINSON, P., STEVENSON, B. J., MCLACHLAN, G., DORIN, J. R. AND PORTEOUS, D. J.: Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Natures Genet. 5: 16-23, 1993.
2. BRIGHAM, K. L., MEYRICK, B., CHRISTMAN, B., MAGNUSON, M., KING, G. AND BERRY, L. C.: In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle. Am. J. Med. Sci. 298: 278-281, 1989.
3. CAPLEN, N. J., ALTON, E. W. F. W., MIDDLETON, P. G., DORIN, J. R., STEVENSON, B. J., GAO, Z., DURHAM, S. R., JEFFERY, P. K., HODSON, M. E., COUTELLE, C., HUANG, L., PORTEOUS, D. J., WILLIAMSON, R. AND GEDDES, D. M.: Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Natures Med. 1: 39-46, 1995.
4. DHARMSATHAPHORN, K., MCROBERTS, J. A., MANDEL, K. G., TISDALE, L. D. AND MASUI, H.: A human colonic tumor cell line that maintains vectorial electrolyte transport. Am. J. Physiol. 246: G204-G208, 1984.
5. ELROY-STEIN, O., FUERST, T. R. AND MOSS, B.: CAP-independent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc. Natl. Acad. Sci. U.S.A. 16: 6126-6130, 1989.
6. ENGELHARDT, J. F., YANKASKAS, J. R., ERNST, S. A., YANG, Y., MARINO, C. R., BOUCHER, R. C., COHN, J. A. AND WILSON, J. M.: Submucosal glands are the predominant site of CFTR expression in the human bronchus. Natures Genet. 2: 240-248, 1992.
7. FELGNER, J. H., KUMAR, R., SRIDHAR, C. N., WHEELER, C. J., TSAI, U. J., BORDER, R., RAMSEY, P., MARTIN, M. AND FELGNER, P. L.: Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. Part I. J. Biol. Chem. 269: 2550-25613, 1994.
8. FELGNER, P. L., GADEK, T. R., HOLM, M., ROMAN, R., CHAN, H. W., WENZ, M., NORTHROP, J. P., RINGOLD, G. M. AND DANIELSEN, M.: Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U.S.A. 84: 7413-7417, 1987.
9. FELGNER, P. L. AND RINGOLD, G. M.: Cationic liposome-mediated transfection. Nature (Lond.) 337: 387-388, 1989.
10. GAO, X. AND HUANG, L.: A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179: 280-285, 1991.
11. GARVER, R. I., GOLDSMITH, K. T., RODU, B., HU, P.-C., SORSCHER, E. J. AND CURIEL, D.: Strategy for achieving selective killing of carcinomas. Gene Ther. 1: 46-50, 1994.
12. HYDE, S. C., GILL, D. R., HIGGINS, C. F., TREZISE, A. E. O., MACVINISH, L. J., CUTHBERT, A. W., RATCLIFF, R., EVANS, M. J. AND COLLEDGE, W. H.: Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature (Lond.) 362: 250-255, 1993.
13. JOHNSON, L. G., OLSON, J. C., SARKADI, B., MOORE, K. L., SWANSTROM, R. AND BOUCHER, R. C.: Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Natures Genet. 2: 21-25, 1992.
14. LITZINGER, D. C. AND HUANG, L.: Phosphatidylethanolamine liposomes: Drug delivery, gene transfer and immunodiagnostic applications. Biochim. Biophys. Acta 1113: 201-227, 1992.
15. LOGAN J., BEBOK, Z., WALKER, L., FELGNER, P., SIEGEL, G. P., FRIZZELL, R., DONG, J.-Y., HOWARD, M., MATALON, S. AND SORSCHER, E. J.: Cationic lipids for CFTR gene transfer. Gene Ther. 2: 38-49, 1995.
16. MERCER, W. E., SHIELDS, M. T., AMIN, M., SAUVE, G. J., APPELLA, E., ROMANO, J. W. AND ULLRICH, S. J.: Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc. Natl. Acad. Sci. U.S.A. 87: 6166-6170, 1990.
17. MORISHIA, R., GIBBONS, G. H., ELLISON, K. E., LEE, W., ZHANG, L., YU, H., KANEDA, Y., OGIHARA, T. AND DZAU, V. J.: Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J. Clin. Invest. 94: 978-984, 1994.
18. NABEL, G. J., NABEL, E. G., YANG, Z.-Y., FOX, B. A., PLAUTZ, G. E., GAO, Z., HUANG, L., SHU, S., GORDON, D. AND CHANG, A. E.: Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity and lack of toxicity in humans. Proc. Natl. Acad. Sci. U.S.A. 90: 11307-11310, 1993.
19. PENG, S., SOMMERFELT, M. A., BERTA, G., BERRY, A. K., KIRK, K., HUNTER, E. AND SORSCHER, E. J.: Rapid purification of recombinant baculovirus using fluorescence activated cell sorting. BioTechniques 14: 274-277, 1993.
20. PHILIP, R., LIGGITT, D., PHILIP, M., DAZIN, P. AND DEBS, R.: In vivo gene delivery. Efficient transfection of T lymphocytes in adult mice. J. Biol. Chem. 268: 16087-16090, 1993.
21. RAM, Z., CULVER, K. W., WALBRIDGE, S., BLAESE, R. M. AND OLDFIELD, E. H.: In situ retroviral mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53: 83-88, 1993.
22. ROSE, J. K., BUONOCORE, L. AND WHITT, M. A.: A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. BioTechniques 10: 520-525, 1991.
23. SLADDEK, T. L. AND JACOBBERGER, F. W.: Flow cytometric titration of retroviral expression vectors: Comparison of methods for analysis of immunofluorescence histograms derived from cells expressing low antigen levels. Cytometry 14: 23-31, 1993.
24. SORSCHER, E. J., FULLER, C. M., BRIDGES, R. J., TOUSSON, A., MARCHASE, R. B., BRINKLEY, B. R., FRIZZELL, R. AND BENOS, D. J.: Identification of a 60 kDa membrane protein from T84 cells using antibodies made against a synthetic DIDS binding peptide. Am. J. Physiol. 262: C136-C147, 1992.
25. SORSCHER, E. J., LOGAN, J., LYRENE, R., FRIZZELL, R., BEBOK, Z., DONG, J.-Y., DUVALL, M. D., FELGNER, P. L., MATALON, S. AND WALKER, L.: Gene therapy for cystic fibrosis using cationic liposome mediated gene transfer: A phase I trial of safety and efficacy in the nasal airway. Human Gene Ther. 5: 1259-1299, 1994a.
26. SORSCHER E. J., PENG, S., BEBOK, Z., ALLAN, P. W., BENNETT, L. L., JR. AND PARKER, W. B.: Tumor cell bystander killing in colonic carcinoma utilizing the E. coli Deo D gene to generate toxic purines. Gene Ther. 1: 233-238, 1994b.
27. ZHU, N., LIGGITT, D., LIU, Y. AND DEBS, R.: Systemic gene expression after intravenous DNA delivery into adult mice. Science (Wash. DC) 261: 209-211, 1993.